Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine versus oral midazolam as premedication for propofol sedation in pediatric MRI
2021-004456-42Phase 3Completed
- Sponsor
- Queen Fabiola Children's University Hospital
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Intranasal dexmedetomidine premedication + propofol sedation with Oral midazolam premedication + propofol sedation (2 arms). Primary endpoint: Incidence and type of undesirable events requiring temporary or definitive interruption of MRI. Started Apr 2022; status: completed.
02
Drugs
dexmedetomidinemidazolampropofol
Beyond the preview
Go deeper on 2021-004456-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-004456-42.